Please complete the CAPTCHA to continue
@abbvie.com
✓
3 phones found area 617 and 781
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Andy Payne is listed as Vice President, Neurotoxins R&D Early Portfolio Strategy and Operations at AbbVie, based in United States, United States, United States. AeroLeads shows a work email signal at abbvie.com, phone signal with area code 617, 781, and a matched LinkedIn profile for Andy Payne.
Andy Payne previously worked as Vice President TA Asset Leadership at Abbvie and Group Project Leader - General Medicine at Abbvie. Andy Payne holds Bsc Phd, Chemistry from University Of Exeter.
This section adds company-level context without repeating Andy Payne's masked contact details.
AeroLeads found 1 current-domain work email signal for Andy Payne. Compare company email patterns before reaching out.
Andy Payne is a Vice President, Neurotoxins R&D Early Portfolio Strategy and Operations at AbbVie. He possess expertise in clinical development, clinical trials, pharmaceutical industry, drug development, clinical research and 15 more skills.
Listed skills include Clinical Development, Clinical Trials, Pharmaceutical Industry, Drug Development, and 16 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
North Chicago, Illinois, US
Leading portfolio strategy across early phase neurotoxins arena across multiple target diseases and neurotoxins. Integration into overall neurotoxins portfolio strategy. Leadership of group of Project Directors who lead research based toxins projects through research into development.
North Chicago, Illinois, US
Functional leadership of Asset Strategy Leaders engaged in asset development and commercialization in immunology, neuroscience, general medicine, infectious disease, ophthalmology and toxins therapeutic areas. Functional voice at therapy area governance.
North Chicago, Illinois, US
Group Project Leader for Asset Development Teams within General Medicine incuding development, NDA submission / approval and commercialization of assets for endometriosis and uterine fibroids. Line management of Project Leaders within General Medicine including Women's and Men's Health, Renal disease, Cystic Fibrosis & Pancreatic Enzyme Insufficiency
North Chicago, Illinois, US
Group Project Leader for Asset Development Teams for Humira new indications and enhancements within immunology culminating in several sBLA submissions and approvals for devices, formulations and new indications in US, EU, Japan. Line management of a group of Project Leaders within Immunology.
North Chicago, Illinois, US
Project Director leading global Project Teams for Humira new indications and enhancements across a spectrum of immunological diseases (eg non-infectious uveitis, RA ) and biosimilar differentiation strategy. Line management of MD contributors to clinical development strategy and execution.
Cambridge, MA, US
Program Director for Avonex and phase III biologic Plegridy for Relapsing Multiple Sclerosis (MS) including BLA submission and sBLA submissions / approvals for new devices. Program Leadership and Management
Cambridge, MA, US
Line management of clinical trial managers and clinical program leaders engaged in design and execution of clinical development plans for biologics and small molecules across phases I, II, III, IV across a variety of neurology indications including MS, pain, Alzheimers, Parkinsons. Leading clinical aspects of Avonex and PEGylated Interferon in MS.
Brentford, Middlesex, GB
Strategic and tactical leadership of cross functional R&D drug development program teams in Phases I, II, IV. Primary focus CNS including depression, generalized anxiety disorder, social anxiety disorder, panic, PTSD, smoking cessation, alcohol addiction, premenstrual dysphoric disorder, bipolar disorder, schizophrenia.
Quick answers generated from the profile data available on this page.
Andy Payne works for AbbVie.
Andy Payne is listed as Vice President, Neurotoxins R&D Early Portfolio Strategy and Operations at AbbVie.
AeroLeads has found 1 work email signal at @abbvie.com for Andy Payne at AbbVie.
AeroLeads has found 3 phone signal(s) with area code 617, 781 for Andy Payne at AbbVie.
Andy Payne is based in United States, United States, United States while working with AbbVie.
Andy Payne has worked for Abbvie, Biogen Idec, and Glaxosmithkline R&D.
You can use AeroLeads to view verified contact signals for Andy Payne at AbbVie, including work email, phone, and LinkedIn data when available.
Andy Payne holds Bsc Phd, Chemistry from University Of Exeter.
Andy Payne is listed with skills including Clinical Development, Clinical Trials, Pharmaceutical Industry, Drug Development, Clinical Research, Biotechnology, R&D, and Regulatory Submissions.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts